While tardive dyskinesia can be distressing, there are treatments available to help manage the symptoms. In some cases, reducing or changing the offending medication can make a significant difference.

What the Research Says About Non-Traditional Approaches to Tardive Dyskinesia In light of the limited scientific consensus in this field, we delve into the evidence surrounding a range of ...

Even though the term tardive dyskinesia was coined about 60 years ago, an "umbrella" term—tardive syndrome—has been gaining acceptance in medical circles. The terms have often been used ...

Tardive dyskinesia (TD) is a neurological disorder brought on by the long-term use of medications that block dopamine, such as antipsychotics. While treatable, TD can have significant physical and ...

Winona Tse, MD, professor of neurology at the Icahn School of Medicine in New York City, discusses some of the theories about how tardive dyskinesia develops in different patients. (2:07) ...

Tardive dyskinesia (TD) is widely known as a potentially irreversible, chronic side effect of long-term dopamine receptor-blocking agent use, typically antipsychotic medications prescribed for ...

"Tardive dyskinesia can affect patients' daily lives, causing pain and anxiety and hindering the ability to perform self-care tasks and to participate in work, family or social life," said Eiry W ...

Aggarwal S, Serbin M, Yonan C. Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia. J Comp Eff Res. 2019;8 (13):1077-1088. doi:10.2217/cer ...

Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J Clin Psychiatry. 2017;78 (3): e264-e278. Hansen TE, Brown WL, Weigel RM, Casey DE.

Session ID: 2025-07-18:4f3fa8dc277d7b36a205158 Player Element ID: V96446f73_6736_47e5_a1b7_da8dad551ebf_6347209446112 ...

Neurocrine is ringing in Tardive Dyskinesia Awareness Week—which takes place during the first full week of May and so kicked off on Sunday—by helping to conduct initiatives across the U.S ...

References: Neurocrine Biosciences announces US FDA accepts New Drug Application for Ingrezza® (valbenazine) oral granules sprinkle formulation. News release. Neurocrine Biosciences. September 14 ...